Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

20.0%

2 terminated/withdrawn out of 10 trials

Success Rate

77.8%

-8.7% vs industry average

Late-Stage Pipeline

30%

3 trials in Phase 3/4

Results Transparency

29%

2 of 7 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

Phase 2

4(57.1%)

Phase 4

2(28.6%)

Phase 3

1(14.3%)

7Total

Phase 2(4)

Phase 4(2)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT02970877Phase 2Completed

Stool Transplantation for Treatment of Insulin Resistance in Morbidly Obese Patients

Role: lead

NCT01943409Phase 4Completed

Intravenous Nutrition in Hospitalized Patients: Comparison of Two Oils

Role: lead

NCT01856465Unknown

Intestinal Microbiota and NAFLD Pre and Post Bariatric Surgery

Role: lead

NCT02796833Phase 4Completed

Comparison of Two Intravenous Lipid Emulsions in Home Parenteral Nutrition Patients

Role: lead

NCT02148471Completed

Fatty Acids, Genes and Microbiota in Fatty Liver

Role: lead

NCT01565278Phase 3Terminated

Fish Oil for Patients With Liver Disease Due to Parenteral Nutrition

Role: lead

NCT01056133Phase 2Completed

Effect of Fish-oil on Non-alcoholic Steatohepatitis (NASH)

Role: lead

NCT00444002Completed

Oxidative Stress and Fatty Acids in Hepatitis C

Role: lead

NCT00152893Phase 2Completed

To Determine if Chromium Nicotinate Supplementation Will Improve Insulin Resistance in HIV Patients With Metabolic Abnormalities

Role: lead

NCT00152815Phase 2Terminated

Non-alcoholic Fatty Liver Disease (NAFLD) in HIV: The Role of Nutritional Interventions

Role: lead

All 10 trials loaded